Treatment of Herpetic Gingivostomatitis

Introduction to Treatment

The Centers for Disease Control and Prevention recommends oral aciclovir as the treatment for herpetic gingivostomatitis, significantly reducing healing time and symptom duration, with a dosage of 20 mg/kg body weight (maximum 400 mg/dose) orally three times daily for 5-10 days for mild cases, or IV therapy for moderate to severe cases 1, 2

For mild symptomatic gingivostomatitis, the American Academy of Pediatrics recommends aciclovir, 20 mg/kg body weight (maximum 400 mg/dose) per dose orally three times daily for 5-10 days 1, 2
For moderate to severe symptomatic gingivostomatitis, the Centers for Disease Control and Prevention recommends aciclovir, 5-10 mg/kg body weight per dose IV three times daily 1, 2
After lesions begin to regress, the American Academy of Pediatrics recommends transitioning to oral aciclovir 1, 2
The Centers for Disease Control and Prevention recommends continuing therapy until lesions completely heal 1, 2

For aciclovir-resistant HSV infection, the Centers for Disease Control and Prevention recommends foscarnet (40 mg/kg body weight per dose IV three times daily or 60 mg/kg body weight per dose IV twice daily) 1, 2
The Journal of Clinical Virology recommends supportive care, including pain management with topical anesthetics or analgesics 3, 4
The Journal of Clinical Virology recommends antipyretics for fever 3, 4

The Journal of Clinical Virology states that topical antivirals are less effective than systemic therapy and are not recommended as first-line treatment 3, 4
The Journal of Clinical Virology states that topical antivirals are not effective for prophylaxis as they cannot reach the site of viral reactivation 3, 4
The FDA has not approved any antiviral agent specifically for primary gingivostomatitis, though aciclovir has demonstrated clear benefits, according to the Journal of Clinical Virology 3, 4